Terms: = Gastric cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2
560 results:
1. Identification and characterization of ferroptosis-related genes in therapy-resistant gastric cancer.
Yu J; Li H; Huang C; Chen H
Medicine (Baltimore); 2024 May; 103(20):e38193. PubMed ID: 38758860
[TBL] [Abstract] [Full Text] [Related]
2. RAC1-mediated integrin alpha-6 expression in E-cadherin-deficient gastric cancer cells promotes interactions with the stroma and peritoneal dissemination.
Zhang J; Fu L; Wang H; Yonemura A; Semba T; Yasuda-Yoshihara N; Nishimura A; Tajiri T; Tong Y; Yasuda T; Uchihara T; Yamazaki M; Okamoto Y; Yamasaki J; Nagano O; Baba H; Ishimoto T
Cancer Lett; 2024 Jun; 591():216901. PubMed ID: 38641311
[TBL] [Abstract] [Full Text] [Related]
3. The Molecular Landscape of gastric cancers for Novel Targeted Therapies from Real-World Genomic Profiling.
Yamamoto H; Arai H; Oikawa R; Umemoto K; Takeda H; Mizukami T; Kubota Y; Doi A; Horie Y; Ogura T; Izawa N; Moore JA; Sokol ES; Sunakawa Y
Target Oncol; 2024 May; 19(3):459-471. PubMed ID: 38613733
[TBL] [Abstract] [Full Text] [Related]
4. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
5. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive Molecular Profiling and Clinicopathological Characteristics of gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.
Nasu H; Nishio S; Park J; Tasaki K; Terada A; Tsuda N; Kawano K; Kojiro-Sanada S; Akiba J; Ushijima K
Kurume Med J; 2024 May; 69(3.4):237-249. PubMed ID: 38369337
[TBL] [Abstract] [Full Text] [Related]
7. Comparative analysis of kras4a and kras4b splice variants reveals distinctive structural and functional properties.
Whitley MJ; Tran TH; Rigby M; Yi M; Dharmaiah S; Waybright TJ; Ramakrishnan N; Perkins S; Taylor T; Messing S; Esposito D; Nissley DV; McCormick F; Stephen AG; Turbyville T; Cornilescu G; Simanshu DK
Sci Adv; 2024 Feb; 10(7):eadj4137. PubMed ID: 38354232
[No Abstract] [Full Text] [Related]
8. Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors.
Aydin Mericoz C; Eren OC; Kulac I; Firat P
Diagn Cytopathol; 2024 May; 52(5):264-270. PubMed ID: 38339821
[TBL] [Abstract] [Full Text] [Related]
9. CDKN2A-p16 Deletion and Activated kras
Sun J; Sepulveda JL; Komissarova EV; Hills C; Seckar TD; LeFevre NM; Simonyan H; Young C; Su G; Del Portillo A; Wang TC; Sepulveda AR
Cell Mol Gastroenterol Hepatol; 2024; 17(5):769-784. PubMed ID: 38296052
[TBL] [Abstract] [Full Text] [Related]
10. Oncogenic Fatty Acid Metabolism Rewires Energy Supply Chain in gastric Carcinogenesis.
Won Y; Jang B; Lee SH; Reyzer ML; Presentation KS; Kim H; Caldwell B; Zhang C; Lee HS; Lee C; Trinh VQ; Tan MCB; Kim K; Caprioli RM; Choi E
Gastroenterology; 2024 May; 166(5):772-786.e14. PubMed ID: 38272100
[TBL] [Abstract] [Full Text] [Related]
11. Biological and targeting differences between the rare kras A146T and canonical kras mutants in gastric cancer models.
Puliga E; De Bellis C; Vietti Michelina S; Capeloa T; Migliore C; Orrù C; Baiocchi GL; De Manzoni G; Pietrantonio F; Reddavid R; Fumagalli Romario U; Ambrogio C; Corso S; Giordano S
Gastric Cancer; 2024 May; 27(3):473-483. PubMed ID: 38261067
[TBL] [Abstract] [Full Text] [Related]
12. A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer.
Han X; Jia X; Sheng C; Li M; Han J; Duan F; Wang K
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102287. PubMed ID: 38253255
[TBL] [Abstract] [Full Text] [Related]
13. Global burden, risk factors, clinicopathological characteristics, molecular biomarkers and outcomes of microsatellite instability-high gastric cancer.
Zhang Z; Huang J; Li Y; Yan H; Xie J; Wang J; Zhao B
Aging (Albany NY); 2024 Jan; 16(1):948-963. PubMed ID: 38224334
[TBL] [Abstract] [Full Text] [Related]
14. Dynamic tuft cell expansion during gastric metaplasia and dysplasia.
Jang B; Kim H; Lee SH; Won Y; Kaji I; Coffey RJ; Choi E; Goldenring JR
J Pathol Clin Res; 2024 Jan; 10(1):e352. PubMed ID: 38117182
[TBL] [Abstract] [Full Text] [Related]
15. RHOA
Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
[TBL] [Abstract] [Full Text] [Related]
16. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
17. Characteristic Mutational Damages in gastric and Colorectal Adenocarcinomas.
Yermekova S; Orazgaliyeva M; Goncharova T; Rakhimbekova F; Kaidarova D; Shatkovskaya O
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3939-3947. PubMed ID: 38019254
[TBL] [Abstract] [Full Text] [Related]
18. Genetic landscape and PD-L1 expression in Epstein-Barr virus-associated gastric cancer according to the histological pattern.
Park JH; Cho HJ; Seo J; Park KB; Kwon YH; Bae HI; Seo AN; Kim M
Sci Rep; 2023 Nov; 13(1):19487. PubMed ID: 37945587
[TBL] [Abstract] [Full Text] [Related]
19. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
20. The ASH1L-AS1-ASH1L axis controls NME1-mediated activation of the RAS signaling in gastric cancer.
Xie M; Zhang L; Han L; Huang L; Huang Y; Yang M; Zhang N
Oncogene; 2023 Nov; 42(46):3435-3445. PubMed ID: 37805663
[TBL] [Abstract] [Full Text] [Related]
[Next]
